| Michael Walleri, DO | |
|
4300 B St Ste 200, Anchorage, AK 99503-5933 | |
| (907) 375-3355 | |
| (907) 562-1603 |
| Full Name | Michael Walleri |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 6 Years |
| Location | 4300 B St Ste 200, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295224400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 133703 (Alaska) | Secondary |
| 208M00000X | Hospitalist | 176205 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Hospitalist Group Llc | 6507755964 | 84 |
News Archive
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
With the latest research estimating that nearly six million people worldwide will lose their lives to tobacco next year, an innovative approach is critical to helping the 43 million Americans who smoke to finally quit. This month, which is observed as Lung Cancer Awareness Month, the national quit smoking program, EX(R) will debut the second phase of advertising and promotions designed to help smokers "re-learn" life without cigarettes.
Although today's rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments to the joints, which could reduce whole-body side effects.
A Cornell University scientist and designer from Africa have together created a fashionable hooded bodysuit embedded at the molecular level with insecticides for warding off mosquitoes infected with malaria, a disease estimated to kill 655,000 people annually on the continent.
Alcon, Inc. announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure.
› Verified 1 days ago
| Entity Name | Alaska Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831296995 PECOS PAC ID: 6507755964 Enrollment ID: O20040312001148 |
News Archive
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
With the latest research estimating that nearly six million people worldwide will lose their lives to tobacco next year, an innovative approach is critical to helping the 43 million Americans who smoke to finally quit. This month, which is observed as Lung Cancer Awareness Month, the national quit smoking program, EX(R) will debut the second phase of advertising and promotions designed to help smokers "re-learn" life without cigarettes.
Although today's rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments to the joints, which could reduce whole-body side effects.
A Cornell University scientist and designer from Africa have together created a fashionable hooded bodysuit embedded at the molecular level with insecticides for warding off mosquitoes infected with malaria, a disease estimated to kill 655,000 people annually on the continent.
Alcon, Inc. announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Walleri, DO 4300 B St, Ste 200, Anchorage, AK 99503-5933 Ph: (907) 375-3355 | Michael Walleri, DO 4300 B St Ste 200, Anchorage, AK 99503-5933 Ph: (907) 375-3355 |
News Archive
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
With the latest research estimating that nearly six million people worldwide will lose their lives to tobacco next year, an innovative approach is critical to helping the 43 million Americans who smoke to finally quit. This month, which is observed as Lung Cancer Awareness Month, the national quit smoking program, EX(R) will debut the second phase of advertising and promotions designed to help smokers "re-learn" life without cigarettes.
Although today's rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments to the joints, which could reduce whole-body side effects.
A Cornell University scientist and designer from Africa have together created a fashionable hooded bodysuit embedded at the molecular level with insecticides for warding off mosquitoes infected with malaria, a disease estimated to kill 655,000 people annually on the continent.
Alcon, Inc. announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure.
› Verified 1 days ago
Casey Mapes, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Stephen C Ellison, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Jonathan Daining, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Dr. Heath Wade Turner, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Alisha Alexandra Skinner, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3355 | |
Esther Lee Hargrave, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Larry Scott Owen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 |